A slight negative trend in the relationship between U-Cd levels and BMD in both 2019 and 2022, as evident from the slightly downward-sloping regression lines in both years. However... by Aroon La-up (14095691)

Subjects:

Procedure of the Loughborough Intermittent Shuttle Test. by Dominic Michael Rasp (19959412)

Subjects:

S1 Raw data - by Dominic Michael Rasp (19959412)

Subjects:

Development of the limb symmetry index (LSI) over the course of the LIST. by Dominic Michael Rasp (19959412)

Subjects:

Development of hamstring strength throughout the LIST. by Dominic Michael Rasp (19959412)

Subjects:

Summary of HSS and LSI during the LIST. by Dominic Michael Rasp (19959412)

Subjects:

S2 Raw data - by Dominic Michael Rasp (19959412)

Subjects:

Set-up of the optimized 90:20 Isometric Posterior Chain Test. by Dominic Michael Rasp (19959412)

Subjects:

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …”

Assignment of interventions to community health centers (CHCs) in districts. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Estimated effects of the intervention packages on the incidence of NCDs metabolic risk factors. by Mehran Asadi-Aliabadi (8383110)

Subjects:

The difference in NCDs metabolic risk factors’ prevalence between the two surveys. by Mehran Asadi-Aliabadi (8383110)

Subjects:

CONSORT flow diagram. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Demographic and economic characteristics of participants (frequencies and percentages). by Mehran Asadi-Aliabadi (8383110)

Subjects:

Districts of intervention and no intervention in IRPONT study. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Flowchart of the screening process. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Characteristics of included reviews. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”